{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:52:42Z","timestamp":1780969962282,"version":"3.54.1"},"reference-count":41,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia","award":["MOE-BU-1-2020"],"award-info":[{"award-number":["MOE-BU-1-2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing organisms are prevalent in both outpatient and inpatient settings, representing the most often encountered forms of infection. This research aimed to estimate the prevalence of ESBL-UTIs along with other uropathogens in the adult population and to assess the antibiotic activity against Escherichia coli extended-spectrum beta-lactamase (E. coli ESBL) isolates from patient samples in Al-Baha. A retrospective cross-sectional study included patients who presented to King Fahad Hospital in Al-Baha with clinical suspicion of UTI between 1 January 2019 and 30 September 2022. A total of 4406 urine samples with significant microbial growth were included in the scope of this investigation. A collective count of 1644 incidents of Escherichia coli (E. coli) was observed, wherein E. coli constituted 85% of the cases, while the remaining 15% comprised E. coli ESBL producers. The prevalence of E. coli ESBL was observed to be 64.7% in females and 35.3% in males, with a majority (67%) of the affected individuals being over the age of 50. The incidence of E. coli infections in the outpatient setting was found to be greater than that observed in the inpatient setting. E. coli ESBL were sensitive to colistin, tigecycline, amikacin, meropenem, imipenem, and nitrofurantoin by 100% and 93.3\u2013100%, 95\u201399.6%, 95\u201399.06%, and 81\u201391%, respectively. On the other hand, the most resistant agents for E. coli ESBL were the group of cephalosporins, aztreonam, and ampicillin with 100% resistance, ciprofloxacin with 56\u201374% resistance, and cotrimoxazole with a 45\u201353% resistance level. ESBL-resistant E. coli strains are moderately prevalent in community- and hospital-acquired UTIs, especially in females and elderly patients (&gt;50 years).<\/jats:p>","DOI":"10.3390\/microorganisms11122820","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:48:45Z","timestamp":1700531325000},"page":"2820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of Extended-Spectrum Beta-Lactamase Resistance in Uropathogenic Escherichia coli Isolates from Urinary Tract Infection Patients in Al-Baha, Saudi Arabia"],"prefix":"10.3390","volume":"11","author":[{"given":"Samiyah Ahmad Abdullah","family":"Alghamdi","sequence":"first","affiliation":[{"name":"Laboratory Medicine Department, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65779, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia Shaheen","family":"Mir","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65779, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez Saad","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Medical Training and Education Department, King Fahad Hospital, Al-Baha 65732, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4753-5411","authenticated-orcid":false,"given":"Mohammad Abdul Majeed Mohammad Aref","family":"Al Banghali","sequence":"additional","affiliation":[{"name":"Public Health Department, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65779, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaia Saleh Rajab","family":"Almalki","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65779, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/postgradmedj-2017-135454","article-title":"Strategy to reduce E. coli bacteraemia based on cohort data from a London teaching hospital","volume":"94","author":"Hsu","year":"2018","journal-title":"Postgrad. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/CCM.0000000000003324","article-title":"Assessing variability in hospital-level mortality among US Medicare beneficiaries with hospitalizations for severe sepsis and septic shock","volume":"46","author":"Hatfield","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.3390\/ijerph120808871","article-title":"Infection control programs and antibiotic control programs to limit transmission of multi-drug resistant Acinetobacter baumannii infections: Evolution of old problems and new challenges for institutes","volume":"12","author":"Chen","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/1389201020666190408095811","article-title":"Healthcare-associated infections due to multidrug-resistant organisms: A surveillance study on extra hospital stay and direct costs","volume":"20","author":"Giraldi","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp070477","article-title":"Resistant gram-negative bacilli: A neglected healthcare crisis?","volume":"64","author":"Lautenbach","year":"2007","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14787210.6.5.751","article-title":"Clinical and economic burden of antimicrobial resistance. Expert Rev","volume":"6","author":"Maragakis","year":"2008","journal-title":"Anti-Infect. Ther."},{"key":"ref_7","first-page":"207","article-title":"Antibiotic resistance mechanism of ESBL producing Enterobacteriaceae in clinical field: A review","volume":"2","author":"Thenmozhi","year":"2014","journal-title":"Int. J. Pure Appl. Biosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41598-020-79791-0","article-title":"Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples","volume":"11","author":"Gharavi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.apjtm.2016.06.011","article-title":"Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya","volume":"9","author":"Mohammed","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"dlab068","DOI":"10.1093\/jacamr\/dlab068","article-title":"Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): A systematic review and meta-analysis","volume":"3","author":"Ling","year":"2021","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shakya, P., Shrestha, D., Maharjan, E., Sharma, V.K., and Paudyal, R. (2017). ESBL production among E. coli and Klebsiella spp. causing urinary tract infection: A hospital based study. Open Microbiol. J., 11.","DOI":"10.2174\/1874285801711010023"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.25007\/ajnu.v11n3a1447","article-title":"Phenotypic and Molecular Study of Extended-Spectrum \u03b2-lactamases Producing Enterobacteriaceae from Urinary Tract Infection in Zakho city, Kurdistan Region\/Iraq","volume":"11","author":"Hasan","year":"2022","journal-title":"Acad. J. Nawroz Univ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2147\/IDR.S256131","article-title":"Treatment failure in urinary tract infections: A warning witness for virulent multi-drug resistant ESBL-producing Escherichia coli","volume":"13","author":"Naziri","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/ijmr.IJMR_172_18","article-title":"Molecular characterization of extended-spectrum \u03b2-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India","volume":"149","author":"Gautam","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6525826","DOI":"10.1155\/2020\/6525826","article-title":"Extended-spectrum \u03b2-lactamase (ESBL) genotypes among multidrug-resistant uropathogenic Escherichia coli clinical isolates from a teaching hospital of Nepal","volume":"2020","author":"Pandit","year":"2020","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shah, C., Baral, R., Bartaula, B., and Shrestha, L.B. (2019). Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1587-3"},{"key":"ref_17","first-page":"47","article-title":"Virulence factors, serotypes and antimicrobial suspectibility pattern of Escherichia coli in urinary tract infections","volume":"2","author":"Kausar","year":"2009","journal-title":"Al Ameen J. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.chom.2012.01.001","article-title":"UPEC hemolysin: More than just for making holes","volume":"11","author":"Justice","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0924-8579(03)00236-X","article-title":"Virulence factors of uropathogenic Escherichia coli","volume":"22","author":"Emody","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Alqasim, A., Abu Jaffal, A., and Alyousef, A.A. (2018). Prevalence of multidrug resistance and extended-spectrum \u03b2-lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Int. J. Microbiol., 2018.","DOI":"10.1155\/2018\/3026851"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Alzahrani, M.A., Ali, M.S., and Anwar, S. (2020). Bacteria causing urinary tract infections and its antibiotic susceptibility pattern at tertiary hospital in Al-Baha region, Saudi Arabia: A retrospective study. J. Pharm. Bioallied Sci., 12.","DOI":"10.4103\/JPBS.JPBS_294_19"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4111\/icu.2019.60.1.46","article-title":"Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species","volume":"60","author":"Koksal","year":"2019","journal-title":"Investig. Clin. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/IDR.S299846","article-title":"Antimicrobial surveillance for bacterial uropathogens in Ha\u2019il, Saudi Arabia: A Five-year multicenter retrospective study","volume":"14","author":"Bazaid","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","article-title":"Emergence of extended-spectrum \u03b2-lactamase urinary tract infections among hospitalized emergency department patients in the United States","volume":"77","author":"Talan","year":"2021","journal-title":"Ann. Emerg. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Abalkhail, A., Al Yami, A.S., Alrashedi, S.F., Almushayqih, K.M., Alslamah, T., Alsalamah, Y.A., and Elbehiry, A. (2022). The Prevalence of Multidrug-Resistant Escherichia coli Producing ESBL among Male and Female Patients with Urinary Tract Infections in Riyadh Region, Saudi Arabia. Healthcare, 10.","DOI":"10.3390\/healthcare10091778"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ofy357","DOI":"10.1093\/ofid\/ofy357","article-title":"Risk factors for community-acquired extended-spectrum beta-lactamase\u2013producing Enterobacteriaceae infections\u2014A retrospective study of symptomatic urinary tract infections","volume":"6","author":"Goyal","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_27","first-page":"35","article-title":"Prevalence of resistant uropathogenic Escherichia coli in Bahrain: A community based study","volume":"31","author":"Saeed","year":"2019","journal-title":"J. Bahrain Med. Soc."},{"key":"ref_28","first-page":"48","article-title":"Increasing incidence of ESBL type Resistance among Urinary Tract Infecting Escherichia coli in New Delhi, India","volume":"1","author":"Anas","year":"2017","journal-title":"Int. J. Pure Appl. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/clinpract11030080","article-title":"Antimicrobial Resistance Patterns and ESBL of Uropathogens Isolated from Adult Females in Najran Region of Saudi Arabia","volume":"11","author":"Alasmary","year":"2021","journal-title":"Clin. Pract."},{"key":"ref_30","first-page":"55","article-title":"Recurrent urinary tract infections in females","volume":"60","author":"Rizvi","year":"2010","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tamadonfar, K.O., Omattage, N.S., Spaulding, C.N., and Hultgren, S.J. (2019). Reaching the end of the line: Urinary tract infections. Microbiol. Spectr., 7.","DOI":"10.1128\/microbiolspec.BAI-0014-2019"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vasudevan, R. (2014). Urinary tract infection: An overview of the infection and the associated risk factors. J. Microbiol. Exp., 1.","DOI":"10.15406\/jmen.2014.01.00008"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gaviria, L.P., Montsant, L., Azuaje, C., Gonz\u00e1lez-D\u00edaz, A., Horcajada, J.P., Lim\u00f3n, E., Vi\u00f1as, M., Espinal, P., and Fust\u00e9, E. (2022). A descriptive analysis of urinary ESBL-producing-escherichia coli in cerdanya hospital. Microorganisms, 10.","DOI":"10.3390\/microorganisms10030488"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_35","first-page":"e13837","article-title":"Increased isolation of extended-spectrum beta-lactamase-producing Escherichia coli from community-onset urinary tract infection cases in Uttarakhand, India","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3855\/jidc.9517","article-title":"Antimicrobial susceptibility of microorganisms causing urinary tract infections in Saudi Arabia","volume":"12","author":"Balkhi","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/CEOR.S396160","article-title":"Impact of Implementing Key Performance Indicators on Catheter-Associated Urinary Tract Infection (CAUTI) Rates Among Adult ICU Patients in Saudi Arabia","volume":"15","author":"Alhabdan","year":"2023","journal-title":"Clin. Outcomes Res."},{"key":"ref_38","first-page":"314","article-title":"Resumen ejecutivo del diagn\u00f3stico y tratamiento de las infecciones del tracto urinario. Gu\u00eda de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC)","volume":"35","author":"Aliaga","year":"2017","journal-title":"Enfermedades Infecc. Y Microbiol. Cl\u00ednica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"bjgp20X711533","DOI":"10.3399\/bjgp20X711533","article-title":"Antibiotic resistance of uropathogenic Escherichia coli and ESBL prevalence in general practice patients over 10 years","volume":"70","year":"2020","journal-title":"Br. J. Gen. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S0950268820003015","article-title":"Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections","volume":"149","author":"Vachvanichsanong","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Alghamdi, S., Berrou, I., Aslanpour, Z., Mutlaq, A., Haseeb, A., Albanghali, M., Hammad, M.A., and Shebl, N. (2021). Antimicrobial stewardship programmes in Saudi hospitals: Evidence from a national survey. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020193"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:25:30Z","timestamp":1760131530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["microorganisms11122820"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11122820","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]}}}